Aryavaan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -25.00%
- Profit Growth -3.68%
- Ebitda -12.12%
- Net Worth -63.80%
- Total Assets 55.79%
About Aryavaan Pharmaceuticals
Aryavaan Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 September 2004 and has a history of 20 years and four months. Its registered office is in Goa, Goa, India.
The Corporate was formerly known as Vastu Shining Builders Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Anirudh Agrawal, Anurag Agrawal, and Krishnakumar Agrawal serve as directors at the Company.
Company Details
- Location
Goa, Goa, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100GA2004PTC007040
- Company No.
007040
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2004
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Who are the key members and board of directors at Aryavaan Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirudh Agrawal  | Director | 16-Mar-2012 | Current |
| Anurag Agrawal | Director | 16-Mar-2012 | Current |
| Krishnakumar Agrawal | Director | 16-Mar-2012 | Current |
Financial Performance of Aryavaan Pharmaceuticals.
Aryavaan Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 25% decrease. The company also saw a slight decrease in profitability, with a 3.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aryavaan Pharmaceuticals?
In 2020, Aryavaan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kayji Real Estate Private Limited.Anirudh Agrawal, Anurag Agrawal and 1 more are mutual person
Dci Pharmaceuticals Private LimitedAnirudh Agrawal, Anurag Agrawal and 1 more are mutual person
Agrawal Minerals (Goa) Private LimitedAnirudh Agrawal, Anurag Agrawal and 1 more are mutual person
- Agrawal Medicaments Private Limited
Anirudh Agrawal, Anurag Agrawal and 1 more are mutual person
- Medizest Pharmaceuticals Private Limited
Anirudh Agrawal, Anurag Agrawal and 1 more are mutual person
- Tyresoles Goa Private Limited
Anirudh Agrawal, Anurag Agrawal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aryavaan Pharmaceuticals?
Unlock and access historical data on people associated with Aryavaan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aryavaan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aryavaan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
